NHI - NYSE

National Health Investors, Inc.

NHI·NYSE

$68.62

-1.7%

Real EstateREIT - Healthcare Facilities

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$3.33B

EPS3.0300

P/E Ratio22.65

Earnings Date08/05/2026

378.53M

Revenue

13%

3Y+36.0%

5Y+14.0%

10Y+52.0%

142.18M

Net Income

3Y+114.0%

5Y-23.0%

10Y-6.0%

240.23M

Operating Cash Flow

15%

3Y+30.0%

5Y+3.0%

10Y+36.0%

National Health Investors, Inc. Profit Bridge

NHI · NYSE

Revenue & Cost of Sales

Revenue378.53M

Cost of Goods Sold (239.60M)

Gross Profit138.93M

Operating Expenses

Operating Expenses (-55.90M)

Operating Income194.83M

Other Income & Taxes

Interest Expense (57.37M)

Other Income/Expense-54.04M

Pretax Income140.79M

Income Tax (0.00)

Net Income142.18M

Net Income

142.18M

Profitability Analysis

Gross Margin

36.7%

Strong gross margins indicate healthy pricing and efficient production or service delivery.

Operating Margin

51.5%

Outstanding operational efficiency. The company generates substantial profit from core operations.

Net Profit Margin

37.6%

Exceptional profitability. The company converts a significant portion of revenue to bottom-line earnings.

Effective Tax Rate

0.0%

Below-average tax rate suggests effective tax planning, favorable jurisdictions, or tax credits.

Profitability Insight

Efficient profit conversion: Minimal margin compression from gross to net indicates lean operations and favorable tax/interest environment.

National Health Investors, Inc. Income Statement

NHI • NYSE

National Health Investors, Inc. Income Statement	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
REVENUE
Revenue	378.5M	335.2M	319.8M	278.2M	298.7M	332.8M	318.1M	294.6M	278.7M	248.5M	229M	177.5M	117.8M	97M	82.7M	78.4M	64.2M	63M	62.3M	150.7M
GROSS PROFIT
Cost of Revenue	(239.6M)	(11.2M)	(11.5M)	(9.8M)	(11.6M)	(9.7M)	(5.8M)	(1.2M)	(960K)	(1M)	(985K)	(620K)	(616K)	(771K)	(0.0)	(2M)	(0.0)	(0.0)	(0.0)	(0.0)
Gross Profit	138.9M	324M	308.3M	268.4M	287.1M	323.2M	312.3M	293.4M	277.7M	247.5M	228M	176.9M	117.2M	96.2M	82.7M	76.4M	64.2M	63M	62.3M	150.7M
OPERATING INCOME
Operating Expenses	-55.9M	(140.2M)	(129.5M)	(135.6M)	(101.8M)	(98.2M)	(92.3M)	(85.4M)	(80.8M)	(70.8M)	(65.1M)	(48M)	(30.8M)	(25.9M)	(20.8M)	(19.9M)	(14.6M)	(13.7M)	(8M)	(100.5M)
Selling, General & Administrative	(0.0)	(21.8M)	(19.8M)	(25.3M)	(19.3M)	(14.6M)	(13.9M)	(12.9M)	(12.7M)	(10.2M)	(11M)	(9.3M)	(10M)	(8.6M)	(8M)	(8.8M)	(7.2M)	(5.2M)	(5.7M)	(5.3M)
Operating Income	194.8M	183.9M	178.8M	132.8M	185.3M	224.9M	220M	209.2M	197.8M	177.7M	163.9M	106.2M	77.8M	71M	61.9M	58.5M	49.6M	49.3M	54.3M	50.2M
PRE-TAX INCOME
Interest Expense	(57.4M)	(56.1M)	(55.5M)	(42.4M)	(48.1M)	(0.0)	(56.3M)	(49.1M)	(0.0)	(43.1M)	(0.0)	(0.0)	(9.2M)	(3.5M)	(3.8M)	(1.6M)	(85K)	(308K)	(4.6M)	(0.0)
Net Interest Income	-33.6M	-56.1M	-58.2M	-42.4M	-48.1M	0.0	-56.3M	-49.1M	0.0	-43.1M	0.0	0.0	-9.2M	-3.5M	-2.7M	-1.6M	9M	2.7M	-4.6M	0.0
Other Expenses	-55.9M	(118.4M)	(109.7M)	(110.3M)	(82.5M)	(83.7M)	(78.4M)	(71.3M)	(67.2M)	(1.7M)	(53.2M)	(38.1M)	(3.3M)	(4.8M)	(12.8M)	(11.1M)	(7.4M)	(8.6M)	(2.4M)	(95.2M)
Total Other Income Expenses Net	-54M	-47.3M	-44.4M	-67.4M	-73.2M	-39.6M	-59.6M	-49.9M	-38.5M	-74.1M	-66.1M	-26.4M	-28.5M	0.0	8M	-707K	0.0	0.0	-3.5M	8.4M
Income Before Tax	140.8M	136.6M	134.4M	65.4M	112M	185.3M	160.4M	154.3M	159.4M	153.5M	149.6M	103.1M	79.5M	74.7M	81.1M	69.4M	64.2M	57.5M	67.6M	62.9M
NET INCOME
Income Tax Expense	(0.0)	-45K	(0.0)	-89K	(66K)	(0.0)	(0.0)	-9.2M	(0.0)	(749K)	-707K	(24.7M)	-17.1M	-12.5M	-19.3M	-10.9M	-14.6M	-8.2M	-42.1M	-18.8M
Net Income	142.2M	138M	135.7M	66.4M	111.8M	185.1M	160.5M	154.3M	159.4M	151.5M	148.9M	101.6M	106.2M	90.7M	81.1M	69.4M	64.2M	57.5M	96.4M	69.2M

SEC Filings

NHI - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	June 01, 2026	May 26, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 29, 2026	May 27, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 04, 2026	May 04, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 04, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 04, 2026	May 04, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 04, 2026	May 04, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 23, 2026	April 20, 2026	2026	View Filing
8-K/A 8-K/A 2026 (Amended) N/A	April 22, 2026	April 20, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 21, 2026	April 20, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 03, 2026	May 27, 2026	2026	View Filing

Showing 1 to 10 of 697 filings

Related Guides

Blog Categories

Continue your NHI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.